Wealth management firms are facing more pitfalls when it comes to WhatsApp.
Bridgewater's founder argues the US is in a stagflationary period, and that the Fed's next chair would damage the central bank's credibility by lowering borrowing costs.
Fidelity was under cyberattack for three days in the summer of 2024.
A number of financial advice firms over the past several years have reported similar data breaches.
Contentious investigation ends, removing a key obstacle standing in the way of Trump's nominee to lead the central bank
The current rules that govern day trading in customer margin accounts were adopted nearly a quarter of a century ago, FINRA said.
A fund manager claims a pre-IPO sponsor hid markups and a 17.5% carry behind a "0/0" SpaceX pitch.
Meanwhile, right-hand man of Bradley Heppner, founder of Beneficient, is scheduled to testify Thursday.
Former SEC attorney Rebecca Fike explains the ethos behind the headline stats.
Roughly 160 foreign investors say the sponsor ignored red flags while a Manhattan tower went bust.
An Idaho couple claims SEC-installed fiduciaries routed mine sale cash away from their $7M judgment.
Regulators say the fund manager allegedly paid old investors with new money — and doctored the books to cover the gap.
He allegedly traded biotech deals in a relative's account. Now he is paying up and out of the industry for two years.
Jeffrey Thomas Higgins allegedly took clients' money for 17 years.
Trump's Fed pick outlined plans to reshape inflation policy as questions swirled over his divestiture plans and commitment to institutional independence.
Shareholder claims Hercules Capital dressed up its NAV while quietly loading up on software debt
The agency says a $16M crypto raise leaned on insurance that never existed — and a "trust fund" that wasn't
The private bank promised a "no-margin-call" Tesla hedge. A new lawsuit claims it delivered the opposite
Proposal would scale back Form PF requirements for some private fund advisors
The trial of Bradley Heppner, the former chair of GWG Holdings and a closely linked company, Beneficient, starts Tuesday in Manhattan federal court.
